Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.
CITATION STYLE
Wiernik, P. H., Gallagher, R. E., & Tallman, M. S. (2018). Acute promyelocytic leukemia. In Neoplastic Diseases of the Blood (pp. 409–463). Springer International Publishing. https://doi.org/10.1007/978-3-319-64263-5_21
Mendeley helps you to discover research relevant for your work.